FDA cautions against ExtenZe counterfeit products
The FDA has asked the consumers not to buy products labeled as ExtenZe with lot numbers 1110075 and F050899. The agency said the counterfeit product’s packaging is similar
Exegenesis Bio and Modalis Therapeutics have entered a research partnership and licence agreement to progress MDL-201, a therapeutic candidate for Duchenne muscular dystrophy (DMD).